Hostname: page-component-848d4c4894-wg55d Total loading time: 0 Render date: 2024-06-06T23:06:42.044Z Has data issue: false hasContentIssue false
  • English
  • Français

Fetal valproate syndrome with coronary arteriovenous fistula: a case report

Part of: Interventional Cardiology

Published online by Cambridge University Press:  18 January 2021

Alper Doğan Open the ORCID record for Alper Doğan [Opens in a new window] ,
Ali Baykan  and
Cagdas Vural
Alper Doğan
Affiliation:
Erciyes University School of Medicine, Division of Pediatric Cardiology, Kayseri, Turkey
Ali Baykan*
Affiliation:
Erciyes University School of Medicine, Division of Pediatric Cardiology, Kayseri, Turkey
Cagdas Vural
Affiliation:
Erciyes University School of Medicine, Division of Pediatric Cardiology, Kayseri, Turkey
*
Author for correspondence: Dr A. Baykan, Erciyes University School of Medicine, Division of Pediatric Cardiology Kayseri, Turkey. Tel: +90 352 2453222. E-mail: alibaykan@yahoo.com
Get access Rights & Permissions [Opens in a new window]

Abstract

Interestingly, our case presenting with coronary AV fistula firstly reported in the literature with fetal valproate syndrome. Although differential diagnosis is sometimes difficult, it can be diagnosed with detailed history, physical examination and appropriate laboratory tests. Fetal valproate syndrome can be prevented by discontinue of the valproic acid especially during first trimester of pregnancy.

Keywords

fetal valproate syndromecoronary AV fistulateratogenes
Type
Brief Report
Information
Cardiology in the Young , Volume 31 , Issue 5 , May 2021 , pp. 853 - 855
Check for updates
Copyright
© The Author(s), 2021. Published by Cambridge University Press

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

Mohd, YH, Green, A. Fetal valproate syndrome: the Irish experience. Ir J Med Sci 2018; 187: 965–968.CrossRefGoogle Scholar
Bromley, RL, Mawer, GE, Briggs, M, et al. The prevalence of neuro developmental disorders in children prenatally exposed to antiepileptic drugs. J Neurol Neurosurg Psychiatry 2013; 84: 637–643.10.1136/jnnp-2012-304270CrossRefGoogle Scholar
Diliberti, JH, Farndon, PA, Dennis, NR, Curry, CJ. The fetal valproate syndrome. Am J Med Genet 1984; 19: 473–481.CrossRefGoogle ScholarPubMed
Clayton-Smith, J, Donnai, D. Fetal valproate syndrome. J Med Genet 1995; 32: 724–727.CrossRefGoogle ScholarPubMed
Mutlu-Albayrak, H, Bulut, C, Çaksen, H. Fetal valproate syndrome. Pediatr Neonatol 2017; 58: 158–164.CrossRefGoogle ScholarPubMed
Shimamura, A, Alter, BP. Pathophysiology and management of inherited bone marrow failure syndromes. Blood Rev 2010; 24: 101.CrossRefGoogle ScholarPubMed
Williams, G, King, J, Cunningham, M, Stephan, M, Kerr, B, Hersh, JH. Fetal valproate syndrome and autism: additional evidence of an association. Dev Med Child Neurol 2001; 43: 202–206.CrossRefGoogle ScholarPubMed
Mori, A, Bruneau, B. TBX5 mutations and congenital heart disease: holt-Oram syndrome revealed. Curr Cardiol Rep 2004; 19: 211–215.Google ScholarPubMed
La Placa, S, Pinello, G, Schierz, IAM, Giuffrè, M, Corsello, G. Coronary artery fistula in down syndrome: a hidden association. J Ultrasound Med 2017; 36: 1282–1283.CrossRefGoogle ScholarPubMed
Yoshida, K, Ryu, T, Ogata, T, et al. An elderly man with Klinefelter syndrome associated with hypertrophic cardiomyopathy, sick sinus syndrome, and coronary arteriovenous fistula. Jpn Circ J 1998; 62: 222–224.CrossRefGoogle ScholarPubMed